By the end of the webinar, participants should be able to:
-
Recognize key clinical clues and multisystem manifestations of AL amyloidosis that should prompt consideration of the disease, particularly in patients presenting with cardiac symptoms.
-
Describe an appropriate diagnostic evaluation and referral pathway for suspected AL amyloidosis, with an emphasis on reducing delays and supporting earlier diagnosis.
-
Explain the importance of multidisciplinary care across cardiology, hematology/oncology, nephrology, and other specialties in evaluating and managing patients with AL amyloidosis.
-
Identify barriers to timely, equitable diagnosis and consider practical opportunities to improve awareness, referral, and care for patients.
